Pharmaceuticals News

Idorsia will publish its Half Year 2026 Financial Reporting on Thursday July 30, at 07:00 CEST. An investor webcast and conference call will be held to discuss the results on the same day. Date:...

LONDON and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of...

H1 2026 revenue H1 activity Revenue of €379.2m at 30 June 2026, nearly stable at CER1 and on a like-for-like basis2 (-0.1%)A 2.5% decline in Q2 at CER and on a like-for-like basis, marked by a solid...

Chiffre d’affaires du 1er semestre 2026 Activité semestrielle Chiffre d’affaires au 30 juin 2026 de 379,2 M€, quasiment stable à TCC1 et périmètre comparable2 (-0,1%)Au deuxième trimestre, un repli...

New Taipei City, Taiwan, July 23, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biotech"), a science-driven biotechnology company dedicated to the development...

RICHMOND, Va., July 23, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced that it will report its second quarter 2026 financial results on Tuesday, August 4,...

Translational and clinical data reinforce IMNN-001's potential to unlock IL-12's anti-tumor power in ovarian cancer within a highly safe, proprietary mechanism First-of-its-kind meeting spotlights...

Deborah Ascheim, M.D., former Capricor Therapeutics CMO, elected to stem cell therapy company Longeveron (LGVN) Board of Directors.

Myriad Genetics will hold its second quarter 2026 earnings conference call at 4:30 pm ET on Thursday, July 30, 2026.

NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation (Precision), a leader in brain–computer interface (BCI) technology, announced the appointment of John Donoghue, Ph.D.,...